TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Edor Kabashi(Inserm), Guy A. Rouleau(Montreal Neurological Institute and Hospital), Christine Vande Velde(Centre Hospitalier de l’Université de Montréal), Ksenia Pochigaeva(Sorbonne Université), Patrick A. Dion(Centre Hospitalier de l’Université de Montréal), William Camu, Vincent Meininger(Sorbonne Université), Paul N. Valdmanis(Centre Hospitalier de l’Université de Montréal), Dan Spiegelman(Montreal Neurological Institute and Hospital), Nicolas Dupré(Hôpital de l'Enfant-Jésus), Pierre‐François Pradat(Sorbonne Université), Lucette Lacomblez(Sorbonne Université), François Salachas(Sorbonne Université), Jean‐Pierre Bouchard(University of the Western Cape), Brendan J. McConkey(University of Waterloo)
Cited by 1,526
Related Papers
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
|New England Journal of Medicine|1994|2.2k
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
|The Lancet|1996|1.3k
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
|Science|2015|980